NASDAQ
0.76USD
0.00 (0.00%)
We have scored 13 news catalysts on IsoPlexis Corporation (ISO) over the past 12 months. Coverage across the window leans positive (average ticker sentiment +0.33). Most of the impact sits in sector energy and price momentum.
Market cap
30.3M
P/E
—
EPS
—
Beta
0.00
52W range
0.6001-3.84
Day range
0.60–0.79
Open
0.71
Prev close
0.76
Volume
111K
Avg volume
39.6K
Dividend
0.00
IPO
2021-10-08
No scored news tagged ISO or its network in the window yet.
Show more ISO articles →IsoPlexis Corporation is a life sciences company dedicated to advancing the development of novel curative treatments and personalized therapeutics. The company's innovative offerings serve a wide international market, spanning North America (United States, Canada), numerous European nations (United Kingdom, Belgium, France, Czech Republic, Spain, Germany, Sweden, Italy, Switzerland), and key Asian and Pacific regions (Israel, China, Taiwan, Singapore, Japan, Australia, Korea). At its core, IsoPlexis provides a proprietary single-cell proteomics platform. This comprehensive system integrates specialized instruments, consumable chips, and advanced software, delivering an end-to-end solution for observing protein activity and function at the individual cellular level. Its instrument lineup includes the IsoLight and IsoSpark systems. For chip consumables, it offers IsoCode chips, designed for multiplexed single-cell functional proteomics, and CodePlex chips, which provide multiplexed analysis for ultra-low volume bulk samples. The IsoSpeak software further enhances the platform, providing robust dimensional data analysis and automating workflows through an intuitive, push-button user interface. This enables rapid, same-day visualization of both single-cell and bulk proteome data. Beyond its core products, IsoPlexis also extends research support and post-warranty services. Established in 2013, the company operates from its base in Branford, Connecticut.
Daily OHLCV with SMA overlays and session pivots. Draw your levels and trendlines on it, or ask the AI analyst what the price is reacting to.
Suppliers, customers, partners and competitors, derived from what the news actually says about IsoPlexis Corporation — not a sector bucket. Click an edge to see the articles that established the link.
Suppliers, customers, partners and competitors of IsoPlexis Corporation, taken from what the news actually said about them rather than from a sector bucket. The count is how many articles established each link.
Latest scored catalyst for ISO: .
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
